Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Esophageal Squamous Cell Carcinoma 12Esophageal Neoplasms 9Uterine Cervical Neoplasms 4Carcinoma, Non-Small-Cell Lung 3Squamous Cell Carcinoma of Head and Neck 2Neoplasm Metastasis 2Lymphatic Metastasis 2Uterine Neoplasms 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Thymoma 1Thymic epithelial tumor 1Solid Tumor Cancer 1Recurrence 1Pathologic Complete Response 1Ovarian Neoplasms 1Neoplasms 1Neoplasm Recurrence, Local 1Nasopharyngeal Carcinoma 1Mouth Neoplasms 1Melanoma 1Lung Neoplasms 1Head and Neck Neoplasms 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Ductal, Breast 1Breast Neoplasms 1

Interventions

Radiotherapy 3Cisplatin 3Fluorouracil 2tislelizumab 1pembrolizumab 1motexafin gadolinium 1Tamoxifen 1Talaporfin 1TP protocol 1Spinal Puncture 1Rhenium 1Radiosurgery 1Poly I-C 1Paclitaxel 1Oxaliplatin 1Mitomycin 1Lomustine 1Irinotecan 1Gemcitabine 1Folfox protocol 1Ethiodized Oil 1Erlotinib Hydrochloride 1Docetaxel 1Cetuximab 1Carboplatin 1Blood Specimen Collection 1Bevacizumab 1Anesthesia, General 1Androgen Antagonists 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Neoplasm Recurrence, Local × TP protocol × Clear all
NCT06532539 2026-04-24

Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma

Shandong Cancer Hospital and Institute

Phase 2 Recruiting
30 enrolled
Gynecologic

Neoplasm Metastasis, Neoplasm Recurrence, Local, Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡